RT Journal Article
SR Electronic
T1 Differential effect of corticosteroid treatment on Influenza, SARS, MERS, and SARS-CoV-2 patients: A meta-analysis and systematic review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.22.21254104
DO 10.1101/2021.03.22.21254104
A1 Ali, Sobur
A1 Uddin, Salman Zahir
A1 Dewan, Md. Nayem
A1 Moniruzzaman, M
A1 Kabir, Mir Himayet
A1 Islam, Mohammad Rafiqul
A1 Monir, Hossain
A1 Hossan, Shanewaz
A1 Nafiz, Tanvir Noor
A1 Rashid, Rumana
A1 Imran, Khan Mohammad
YR 2021
UL http://medrxiv.org/content/early/2021/03/26/2021.03.22.21254104.abstract
AB Background Corticosteroid has been used to manage inflammation caused by many diseases including respiratory viral infections. Many articles are available to support the good and bad side of this steroid use but remain inconclusive. To find some evidence about the safety of the drug, we investigated the effect of corticosteroids on the mortality of patients with respiratory viral infections including SARS-CoV-2, SARS, MERS, and Influenza.Method We searched articles in PubMed, Scopus, Cochrane, Medline, Google Scholar, and Web of Science records using keywords “corticosteroid” or “viral infection” or “patients” or “control study”. Mortality was the primary outcome.Result Our selected 24 studies involving 16633 patients were pooled in our meta-analysis. Corticosteroid use and overall mortality were not significantly associated (P=0.176), but in subgroup analysis, corticosteroid use was significantly associated with lower mortality in the case of SARS (P=0.003) but was not significantly associated with mortality for Influenza (H1N1) (P=0.260) and SARS-CoV-2 (P=0.554). Further analysis using study types of SARS-CoV-2, we found that corticosteroid use was not significantly associated with mortality in the case of retrospective cohort studies (P=0.256) but was significantly associated with lower mortality in the case of randomized control trials (P=0.005). Our findings uncover how the outcome of particular drug treatment for different diseases with comparable pathogenesis may not be similar and, RCTs are sometimes required for robust outcome data.Conclusion At the beginning of the COVID-19 pandemic, data of corticosteroid use from other viral infections along with COVID-19 observational and retrospective cohort studies created confusion of its effect, but randomized control trials showed that corticosteroid can be used to treat COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) disclosed that this research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work did not require ethical approval as it does not involve any human or animal experiment.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be made available upon request.RCTRandomized Control TrialRCSRetrospective Cohort StudySARSSevere acute respiratory syndromeMERSMiddle East Respiratory SyndromeSARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus 2H1N1Hemagglutinin (H) and Neuraminidase (N)